References
- Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al, International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, European Society of Intensive Care Medicine, European Respiratory Society, International Sepsis Forum, Japanese Association for Acute Medicine, Japanese Society of Intensive Care Medicine, Society of Critical Care Medicine, Society of Hospital Medicine, Surgical Infection Society, World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296 - 327; http://dx.doi.org/10.1097/01.CCM.0000298158.12101.41; PMID: 18158437
- Angus DC. The search for effective therapy for sepsis: back to the drawing board?. JAMA 2011; 306:2614 - 5; http://dx.doi.org/10.1001/jama.2011.1853; PMID: 22187284
- Suffredini AF, Munford RS. Novel therapies for septic shock over the past 4 decades. JAMA 2011; 306:194 - 9; http://dx.doi.org/10.1001/jama.2011.909; PMID: 21750297
- http://www.nobelprize.org/nobel_prizes/medicine/laureates/2011/advanced-medicineprize2011.pdf
- Triantafilou M, Mouratis M, Lepper PM, Haston RM, Baldwin F, Lowes S, et al. Serum proteins modulate lipopolysaccharide and lipoteichoic acid–induced activation and contribute to the clinical outcome of sepsis. Virulence 2012; In press